Coagulopathy seems to be central to the worsening of COVID-19 symptoms, posing a unique challenge for the management of patients with this novel disease.
Join experts George A. Fritsma, Proprietor of The Fritsma Factor, and Andrew J. Goodwin, MD, Division Chief for Clinical Laboratory Medicine and the CLIA Medical Director for University of Vermont Medical Center Laboratories, for a complimentary webinar discussing the various models that attempt to explain this phenomenon.
Time: Tuesday, September 15, 2020 5:00 PM - 6:00 PM EDT (UTC / GMT - 21:00:00)
Andrew J. Goodwin, MD
CLIA Medical Director, University of Vermont Medical Center (UVMMC), Laboratory Services/Section Medical Director, Thrombosis and Hemostasis Laboratory at UVMMC/Division Chief, Clinical Pathology
Dr. Goodwin is AP/CP Board Certified and serves as the Division Chief for Clinical Laboratory Medicine and the CLIA Medical Director for University of Vermont Medical Center Laboratories. His expertise is laboratory testing for hemostatic and thrombotic disorders. His scholarly work focuses on thrombosis risk in cancer, pre-analytic variables impacting coagulation laboratory testing, and D-dimer testing. He currently serves as Vice Chair for the College of American Pathologists (CAP) Accreditation Education Committee and has served as Vice Chair for the CAP Hemostasis and Thrombosis Committee. He is the Deputy Regional Commissioner for the Northeast Region for the CAP Laboratory Accreditation Program. He provides formal teaching in coagulation laboratory medicine and neoplastic pathology at the Larner College of Medicine at the University of Vermont, and he has developed a Laboratory Management Course and Assistant Medical Directorship for resident trainees in Pathology and Laboratory Medicine.
George A. Fritsma, MS, MLS
Proprietor, The Fritsma Factor, Your Interactive Hemostasis Resource/Educational consultant, BioMedica Diagnostics, Inc.
George consults for the Laboratory Medicine Division of the Pathology Department, University of Alabama at Birmingham School of Medicine, and is an Associate Professor with Michigan State and Rutgers Universities. He is a consulting editor for the Clinical Laboratory Science journal and contributing author for Rodak’s Hematology, published in 2019. He is also scientific advisor for BioMedica Diagnostics, Inc. George holds a Bachelor of Science degree in biology and chemistry from Calvin University and a Masters in Medical Laboratory Science from Wayne State University. He provides resources and education through his blog, The Fritsma Factor, Your Interactive Hemostasis Resource, www.fritsmafactor.com.
This webinar is supported by an educational grant from BioMedica Diagnostics, Inc., a member of the Scotia Investments family of companies.